Varaprasad Reddy appointed chairman of Shantha Biotechnics, Harish Iyer is CEO
13 Jun 2011
Sanofi Pasteur, the vaccines division of the Sanofi-Aventis Group, today announced the appointment f Varaprasad Reddy, founder of Shantha, as chairman of the board. He was the managing director of Shantha Biotechnics.
The company also appointed Harish Iyer as the chief executive officer (CEO) of Shantha Biotechnics.
"Iyer will report directly to Olivier Charmeil, president and CEO of Sanofi Pasteur, and will be a member of the Sanofi Pasteur management committee," Sanofi Pasteur said in a statement.
"Iyer's arrival materialises our engagement to invest in the company; his experience and dynamism will be key assets to lead Shantha in this new phase of its development," Charmeil added.
Iyer was working with Biocon as vice-president and head of R&D.
Sanofi Pasteur, a world leader in the vaccine industry, acquired Hyderabad-based Shantha Biotechnics in 2009. Sanofi Pasteur offers a broad range of vaccines that protect against 20 infectious diseases.
